Guatemala Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Guatemala Pharmaceuticals and Healthcare Report

Guatemala Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Guatemala Pharmaceuticals and Healthcare Report
Published Oct 08, 2016
49 pages — Published Oct 08, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

Guatemala has the largest pharmaceutical market in Central America. However, its per capita spending on medicines is among the lowest in the region (USD-- in ----). ...By ----, we forecast this to increase to --.- of healthcare spending and -.- of GDP. The commercial incentives for foreign drugmakers to further expand in Guatemala s pharmaceutical market are limited by the country s low per capita pharmaceutical spending and subdued market growth. However, in spite of this, the country will continue to attract investment as a regional pharmaceutical production hub and tax incentives are available to encourage foreign investment. The key risks to our projection are high levels of bureaucracy, corruption, the complex judicial system and low security due to non-political violence.

...Relations between Guatemala and Belize are likely to remain tense in the coming quarters, after a recent flare-up in the long-running territorial dispute between the two countries. This will temper cooperation on key economic and security policies and act as an additional deterrent for foreign companies considering investing in the disputed region. ...Relations between Guatemala and Belize are likely to remain tense in the coming quarters, after a recent flare-up in the long-running territorial dispute between the two countries. This will temper cooperation on key economic and security policies and act as an additional deterrent for foreign companies considering investing in the disputed region. The International Commission against Impunity in Guatemala s plan to crack down on local-level corruption in Guatemala will have only a modest near-term impact. ...The International Commission against Impunity in Guatemala s plan to crack down on local-level corruption in Guatemala will have only a modest near-term impact. Indeed, limited resources and a failure by Guatemalan legislature to put robust anti-impunity reforms in place will undermine the UN-backed body s efforts, ensuring that corruption will continue to undermine the operating environment in the years ahead.

...BMI s Risk/Reward Index (RRI) looks to provide a globally comparative and numerically based assessment of a market s attractiveness to innovative drugmakers looking to launch a new medicine in a country. In our Q--- RRI Guatemala maintains its score of --.- out of --- and moves up one position to --th place out of -- countries analysed in the Middle East and Africa (MEA) region. ...

  
Source:
Document ID
2397-3056
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Guatemala Pharmaceuticals and Healthcare Report" Oct 08, 2016. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Guatemala-Pharmaceuticals-and-Healthcare-Report-2026-1919>
  
APA:
Business Monitor International - Industry Reports. (2016). Guatemala Pharmaceuticals and Healthcare Report Oct 08, 2016. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Guatemala-Pharmaceuticals-and-Healthcare-Report-2026-1919>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.